Home » AstraZeneca’s Brilique Licensed in UK
AstraZeneca’s Brilique Licensed in UK
A new drug which can reduce the risk of dying from a second heart attack by one fifth more than the current gold standard, has been licensed for use in Britain.
The Telegraph
The Telegraph
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May